1.
Plasminogen Activator Inhibitor-1 and Cardiovascular Diseases
纤溶酶原激活物抑制剂-1与心血管疾病
2.
Inhibitory effect of green tea polyphenols on plasminogen activator inhibitor-1 expression
绿茶多酚对纤溶酶原激活物抑制剂-1表达影响
3.
Plasma Concentrations Changes and Significance of Plasminogen Activator, Plasminogen Activator Receptor and Plasminogen Activator Inhibitor-1 in Chronic Glomerulonephritis and the Intervenient Research on Them;
慢性肾小球肾炎血浆纤溶酶原激活物及其受体和纤溶酶原激活物抑制剂的变化与干预研究
4.
The Role of the Plasminogen Activator Inhibitor-1 in the Pathogenesis of Hepatic Fibrosis;
纤溶酶原激活物抑制剂-1在肝纤维化发生中的作用
5.
Cytokine-induced release of plasminogen activator inhibitor-1 by human pleural mesothelial cells
细胞因子诱导人胸膜细胞释放纤溶酶原激活物抑制剂-1的研究
6.
Research Progress of Plasminogen Activator Inhibitor One in Gestational Diabetes Mellitus
纤溶酶原激活物抑制剂-1（PAI-1）与妊娠期糖尿病的研究
7.
The Effect of Amiloride-an Inhibitor of Urokinase on the Pathology of Rat COPD Model;
尿激酶型纤溶酶原激活物抑制剂—氨氯吡咪对大鼠COPD模型病理改变的影响
8.
Role of Thrombomodulin and Plasminogen Activator Inhibitor-1 in Diabetic Retinopathy;
血栓调节蛋白和纤溶酶原激活物抑制剂-1在糖尿病视网膜病变中的作用
9.
Relationship between Sepsis and a 4G/5G Polymorphism Within the Promoter Region of Plasminogen Activator Inhibitor-1 (PAI-1) Gene;
纤溶酶原激活物抑制剂-1基因启动子区4G/5G多态性与脓毒症发生发展的相关性
10.
The Effects of CRP on the Expression of PGI_2、PAI-1 in ECV304 Cells;
C反应蛋白对内皮细胞株ECV304细胞释放前列环素、纤溶酶原激活物抑制剂的影响
11.
The Correlation between 4G/5G Polymorphism in Promoter Region of PAI-1 Gene and Coronary Artery Disease;
纤溶酶原激活物抑制剂-1基因启动子区4G/5G多态性与冠心病的关系
12.
Effect of Arotinolol on High-sensitive C-reactive Protein and Plasminogen Activator Inhibitor-1 in Patients with Unstable Angina
阿罗洛尔对不稳定型心绞痛患者高敏C反应蛋白和纤溶酶原激活物抑制剂-1含量的影响
13.
The relation of plasma plasminogen activator inhibitor activity and coronary heart disease
纤溶酶原激活抑制物活性与冠心病发病关系
14.
Relationship between plasminogen activator inhibitor 1 and neuroblastoma
纤溶酶原激活物抑制物1与神经母细胞瘤
15.
The Effect of Astragalus and Safflower Mixture on Expression of Plasminogen Activator Inhibitor 1 in Renal Tubulointerstitial Fibrosis in Rats with Unilateral Ureteral Obstruction;
芪红合剂对肾间质纤维化模型大鼠肾组织中纤溶酶原激活物抑制物-1表达的影响
16.
Analysis of the Relationship Between Thrombin Activatable Fibrinolysis Inhibitor and Fibrinogen in Patients with Coronary Atherosclerotic Heart Disease
冠心病患者凝血酶激活的纤溶抑制物与纤维蛋白原关系分析
17.
Effects of Tang Maiping on Plasminogen Activeator Inhibior in Blood Vessel of Type 2 Diabetic Rats
糖脉平对2型糖尿病大鼠血管纤溶酶原激活抑制剂表达的影响
18.
Epidermal growth factor differently modulate activity of urokinase plasminogen activator and plasminogen ac-tivator inhibitor-1 in oral squamous cell carcinoma and metastasis carcinoma cell lines
外源性表皮生长因子对口腔鳞癌细胞系尿激酶型纤溶酶原激活剂及其抑制剂活性的影响